LURASIDONE SUN (Sun Pharma ANZ Pty Ltd)
Product name
LURASIDONE SUN
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
132 working days (255)
Active ingredients
lurasidone hydrochloride
Registration type
New generic medicine
Indication
LURASIDONE SUN (tablet) is indicated for the treatment of schizophrenia in adults and adolescents (aged 13 to 17 years).